How effective are the current COVID-19 vaccines as the virus continues to evolve?

Publicly released:
International
Photo by Mathurin NAPOLY / matnapo on Unsplash
Photo by Mathurin NAPOLY / matnapo on Unsplash

The COVID-19 vaccines currently available in Australia are still effective, especially against hospitalisation and death, but their effectiveness has dropped as new variants come through, according to research from the US. The team compared COVID-19 outcomes in about 1.8 million people in the US, about 12% of whom had been boosted or vaccinated with one of the newer vaccines targeting subvariant XBB.1.5 (the vaccines currently preferred in Australia.) Comparing with the general population, which includes unvaccinated people and people vaccinated with earlier versions of the vaccines, the researchers calculated the XBB.1.5 vaccines were 52.2% effective against symptomatic infection after four weeks, down to 32.6% and 20.4% at 10 and 20 weeks respectively. Effectiveness against hospitalisation at four and 10 weeks respectively was 66.8% and 57.1%, the researchers say, and effectiveness against death was higher but less certain because there were very few deaths. They say over the course of the study, effectiveness appeared to reduce somewhat as newer, non XBB.1.5 variants began spreading.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page The URL will go live after the embargo ends
Journal/
conference:
New England Journal of Medicine
Research:Paper
Organisation/s: University of North Carolina, USA
Funder: Supported by a Dennis Gillings Distinguished Professorship (to Dr. Lin) and by grants (R01 HL149683 and AI029168) from the National Institutes of Health (to Dr. Lin and Dr. Xu).
Media Contact/s
Contact details are only visible to registered journalists.